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Abstract
Newborn screening is performed under public health authority, with analysis carried out primarily 
by public health laboratories or other centralized laboratories. Increasingly, opportunities to 
improve infant health will arise from including screening tests that are completed at the birth 
centers instead of in centralized laboratories, constituting a significant shift for newborn screening. 
This report summarizes a framework developed by the US Secretary of Health and Human 
Services Advisory Committee on Heritable Disorders in Newborns and Children based on a series 
of meetings held during 2011 and 2012. These meetings were for the purpose of evaluating 
whether conditions identifiable through point-of-care screening should be added to the 
recommended universal screening panel, and to identify key considerations for birth hospitals, 
public health agencies, and clinicians when point-of-care newborn screening is implemented.
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In 2011, the US Secretary of Health and Human Services Advisory Committee on Heritable 
Disorders in Newborns and Children (SACHDNC) recommended that newborns be screened 
for critical congenital heart disease (CCHD) by pulse oximetry. This recommendation was 
made on the basis of evidence of the effectiveness of screening and the benefit of early 
intervention in improving child health.1 Other than screening for CCHD and congenital 
hearing loss, public health newborn screening (NBS) relies on centralized laboratories to 
analyze infant samples (i.e., dried-blood spots). At the time the CCHD recommendation was 
made, the SACHDNC recognized that state public health departments faced significant 
challenges in adopting screening recommendations that did not involve centralized 
laboratories.
The central issue is to determine the extent to which NBS that occurs outside of centralized 
laboratories should be overseen by NBS programs, as distinct from being conducted within 
the context of usual clinical care under the supervision of local health-care providers. The 
SACHDNC recognized the need to develop a standard approach to evaluating nursery-based 
NBS. Over a 1-year period, the SACHDNC developed a framework for considering nursery-
based NBS that does not rely on centralized laboratories. This report describes the findings 
from this work, including key definitions, specific challenges, criteria for determining 
whether screening should be recommended, and the unique roles and responsibilities related 
to such screening activities.
POINT-OF-CARE NBS
Point-of-care (POC) testing includes tests administered and interpreted outside of a 
laboratory but close to the site of direct delivery of medical care to a patient.2 POC-NBS 
differs from the expected usual care provided by the health-care system in that the former 
includes universal access to follow-up diagnosis and treatment, aided by some degree of 
public health oversight. Usual care does not include these attributes, although it reflects 
current standards for care delivery, is supported by clinical guidelines produced by 
professional societies, and includes screening for a wide array of conditions (e.g., for 
conditions such as congenital hip dysplasia and visual impairment by physical examination 
even of newborns who appear to be well). Evidence-based recommendations for such 
clinical preventive approaches to care for newborns are available from sources such as 
Bright Futures and the United States Preventive Services Task Force.3,4 However, these 
components of routine care are not provided under public health authority, nor do public 
agencies provide direct oversight for performing screening, ensuring uniform quality of 
procedures, follow-up care, and reporting. A key feature of NBS, regardless of how it is 
implemented, is that it assures universal access to diagnostic and follow-up treatment 
services, and therefore plays an important role in eliminating disparities as regards 
management of clinical conditions of public health importance.
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CHALLENGES RELATED TO SCREENING FOR CONGENITAL HEARING 
LOSS AND CCHD
In the 1990s, screening of newborns for the early identification of hearing loss began 
through hospital-based initiatives. By 2002, early detection and intervention programs for 
hearing loss were established as part of the public health system in all 50 states and the 
District of Columbia.5 Unlike NBS, which is based on the analysis of dried-blood spots 
within centralized laboratories, the screening test for congenital hearing loss is conducted in 
the newborn nursery and is based on an assessment of physiologic parameters (e.g., auditory 
evoked brainstem response, otoacoustic emissions)6 with diagnostic follow-up being 
available for infants with abnormal test results, who receive outpatient care by the age of 3 
months. To implement the public health mandate for newborn hearing screening, birth 
hospitals acquired the necessary equipment; developed protocols to assure screening and 
communication of results to families, health-care providers, and state public health agencies; 
and trained their personnel in these protocols.7 Although nearly all newborns in the United 
States are screened for hearing loss before being discharged from the hospital,8 ensuring 
follow-up for infants with abnormal results remains a challenge.9,10 There has been no 
standardized approach to screening programs for hearing loss as regards the operation of the 
program and the responsibilities of various entities. In some states, the newborn hearing 
screening program assumes responsibility for monitoring hospital screening programs, 
follow-up of newborns who did not pass the screening, and tracking and reporting progress 
in these infants. In other states, the tracking of infants with abnormal results is primarily the 
responsibility of the institutions in which the testing was performed. In most states, the 
responsibility of public health authorities as regards NBS for hearing loss is primarily 
related to surveillance rather than individual case management, probably contributing to 
incomplete follow-up and reporting.9
As with congenital hearing loss, CCHD screening requires a physiologic test (i.e., pulse 
oximetry). However, unlike screening for congenital hearing loss, those with a positive 
result in the test for CCHD require urgent diagnostic testing before being discharged from 
the hospital. Important challenges as regards implementation include the need for a validated 
screening algorithm that takes into account local effects such as altitude differences between 
nurseries, as yet undeveloped quality assurance methods for the screening test, difficulties 
that some newborn nurseries face in obtaining off-site diagnostic testing capabilities, and the 
lack of established methods to report screening results and diagnostic follow-up data to the 
states’ NBS programs.
CRITERIA FOR POC-NBS
In developing recommendations for POC-NBS, the SACHDNC will first evaluate the extent 
to which the following four criteria are met: (i) urgent treatment of the condition is required 
earlier than the feasible turnaround time for a public health laboratory; (ii) the screening is 
based on physiologic testing that requires the presence of the newborn at the time the results 
are generated; (iii) the public health impact of screening for early diagnosis and treatment is 
of sufficient importance; and (iv) universal screening and/or follow-up and treatment for the 
condition are not currently performed under standard clinical practice. The first two criteria 
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establish the need for POC screening. The first criterion, namely, the need for urgent 
treatment and therefore for rapid turnaround of a test, is the strongest argument for POC 
screening. The second criterion, namely, the need for the presence of the newborn for a 
physiologic test (e.g., hearing screening), is a compelling but less crucial argument. The 
SACHDNC would not need to consider this criterion if the first were met. However, the 
SACHDNC would consider the need for the presence of the newborn for a physiologic test 
if there were compelling evidence that universal screening was not feasible outside of the 
newborn nursery. The third and fourth criteria establish the need for screening within a 
public health context. Both of these would need to be met before recommending the 
adoption of POC-NBS for the condition.
For conditions that meet these criteria, consideration for inclusion in the recommended 
universal screening panel should include an assessment of the feasibility of decentralized 
implementation, including not only the screening test but also the follow-up services. Before 
POC-NBS is recommended, it must be demonstrated that screening technology is readily 
available and can be standardized, that the screening protocol can feasibly be administered 
in the often chaotic newborn nursery setting without significant loss of clinical validity, and 
that appropriate follow-up diagnosis and care can be begun promptly for those with a 
positive test result. Ultimately, the decision about whether a condition meets the threshold 
for POC-NBS is predicated upon evidence that substantially better health outcomes are 
attainable if screening is performed under a public health mandate than can feasibly be 
obtained through usual clinical care.
ROLES AND RESPONSIBILITIES IN POC-NBS
Table 1 summarizes roles and responsibilities for public health programs and health-care 
providers across the components of POC-NBS. The extent to which public health agencies 
are directly involved in POC-NBS will depend on the legislation and regulations authorizing 
the particular screening test within each state. Factors that can help determine the degree of 
public health involvement include the risk of a missed affected case; the complexity of the 
screening procedure; whether the screening test is already a component of standard clinical 
care; the challenge of providing confirmatory diagnostic follow-up testing after an abnormal 
screening test result; and variability between sites as regards quality measures related to 
screening, diagnosis, and health outcomes. Regardless of the level of involvement, public 
health departments should, at a minimum, have roles in informing the public about new 
screening tests for conditions; facilitating standardized implementation of screening; 
participating in quality assurance; developing systems for diagnostic confirmation and 
follow-up; data collection on screening and diagnosis; and evaluating the extent to which the 
NBS is effective in improving child health. For some screening procedures or conditions, 
public health authorities may need to take a greater role in implementation and follow-up for 
POC screening than for others that can be undertaken within the context of routine care. For 
example, if screening for a condition requires special equipment or staff training, public 
health expertise may be needed for establishing standardized procedures and for evaluation 
of the quality of the implementation. Also, if availability of confirmatory diagnostic testing 
or treatment exists at only a limited number of sites, public health agencies could help 
facilitate transfer of patient care. For example, public health agencies might play a role in 
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financing these rare but potentially costly activities. For some conditions, public health roles 
may be limited to educating the public and providers and standardizing the implementation.
COSTS RELATED TO POC-NBS
Central to the success of POC-NBS will be the availability of sufficient funding to meet the 
needs of a comprehensive screening program. Undoubtedly, this will require commitments 
from state legislatures as well as from payers. As with any screening program, the costs 
associated with POC-NBS include the costs of testing as well as follow-up. Important costs 
in addition to those associated with the actual administration of the screening test include 
those associated with purchase of screening equipment, start-up and continuation of hospital 
staff training, the development of information systems to track short- and long-term follow-
up data, entering of results into these information systems, quality assurance monitoring, and 
program evaluation. The scientific evidence that underlies the need for screening, diagnosis, 
and treatment must provide a clear rationale for allocation of resources from clinical care 
and public health agencies to support POC-NBS programmatic activities.
SUMMARY AND NEXT STEPS
We expect that the number of conditions to be considered by the SACHDNC for inclusion in 
POC-NBS will continue to increase. It is likely that the continued development of rapid 
testing methodologies will yield a larger number of screening tests that can be done in the 
newborn nursery, transforming how NBS services are delivered. In contrast to usual clinical 
care, screening with public health oversight helps to ensure universal access and uptake of 
testing; high-quality standardized screening; coordinated follow-up with effective linkage to 
diagnosis, intervention, and family support; and surveillance. Expanding the use of 
electronic medical records and health information exchanges may help with documentation 
of screening and tracking of population health; such strategies will facilitate public health 
monitoring and evaluation of the delivery of POC-NBS services, from test administration 
through short- and long-term follow-up. The SACHDNC will continue to make 
recommendations for NBS based on the potential benefit of screening on health outcomes. 
At the same time, the SACHDNC will also consider feasibility in making recommendations 
regarding POC-NBS.
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Table 1
Summary of roles and responsibilities related to point-of-care newborn screening
Component Public health agencies Health-care providers





Ensure all newborns are screened
Participate in quality assurance
Educate families
Document results
Share results with families
Diagnostic evaluation Ensure the availability of diagnostic evaluation Ensure that those with an abnormal screening result receive 
timely diagnostic evaluation
Surveillance Track results of screening and diagnostic evaluation Report results of screening and diagnostic evaluation
Long-term follow-up Monitor long-term follow-up Provide long-term follow-up
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